Cost-Effectiveness of Routine Type and Screens in Select Endonasal Skull Base Surgeries
Thieme. All rights reserved..
Objective The study aimed to evaluate the cost-effectiveness of obtaining preoperative type and screens (T/S) for common endonasal skull base procedures, and determine patient and hospital factors associated with receiving blood transfusions. Study Design Retrospective database analysis of the 2006 to 2015 National (nationwide) Inpatient Sample and cost-effectiveness analysis. Main Outcome Measures Multivariate regression analysis was used to identify factors associated with transfusions. A cost-effectiveness analysis was then performed to determine the incremental cost-effectiveness ratio (ICER) of obtaining preoperative T/S to prevent an emergency-release transfusion (ERT), with a willingness-to-pay threshold of $1,500. Results A total of 93,105 cases were identified with an overall transfusion rate of 1.89%. On multivariate modeling, statistically significant factors associated with transfusion included nonelective admission (odds ratio [OR]: 2.32; 95% confidence interval [CI]: 1.78-3.02), anemia (OR: 4.42; 95% CI: 3.35-5.83), coagulopathy (OR: 4.72; 95% CI: 2.94-7.57), diabetes (OR: 1.45; 95% CI: 1.14-1.84), liver disease (OR: 2.37; 95% CI: 1.27-4.43), pulmonary circulation disorders (OR: 3.28; 95% CI: 1.71-6.29), and metastatic cancer (OR: 5.85; 95% CI: 2.63-13.0; p < 0.01 for all). The ICER of preoperative T/S was $3,576 per ERT prevented. One-way sensitivity analysis demonstrated that the risk of transfusion should exceed 4.12% to justify preoperative T/S. Conclusion Routine preoperative T/S does not represent a cost-effective practice for these surgeries using nationally representative data. A selective T/S policy for high-risk patients may reduce costs.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:83 |
---|---|
Enthalten in: |
Journal of neurological surgery. Part B, Skull base - 83(2022), Suppl 2 vom: 14. Juni, Seite e449-e458 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Spillinger, Aviv [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anterior skull base |
---|
Anmerkungen: |
Date Revised 16.07.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1055/s-0041-1730896 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM343532778 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM343532778 | ||
003 | DE-627 | ||
005 | 20231226020654.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1055/s-0041-1730896 |2 doi | |
028 | 5 | 2 | |a pubmed24n1145.xml |
035 | |a (DE-627)NLM343532778 | ||
035 | |a (NLM)35832951 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Spillinger, Aviv |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cost-Effectiveness of Routine Type and Screens in Select Endonasal Skull Base Surgeries |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 16.07.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Thieme. All rights reserved. | ||
520 | |a Objective The study aimed to evaluate the cost-effectiveness of obtaining preoperative type and screens (T/S) for common endonasal skull base procedures, and determine patient and hospital factors associated with receiving blood transfusions. Study Design Retrospective database analysis of the 2006 to 2015 National (nationwide) Inpatient Sample and cost-effectiveness analysis. Main Outcome Measures Multivariate regression analysis was used to identify factors associated with transfusions. A cost-effectiveness analysis was then performed to determine the incremental cost-effectiveness ratio (ICER) of obtaining preoperative T/S to prevent an emergency-release transfusion (ERT), with a willingness-to-pay threshold of $1,500. Results A total of 93,105 cases were identified with an overall transfusion rate of 1.89%. On multivariate modeling, statistically significant factors associated with transfusion included nonelective admission (odds ratio [OR]: 2.32; 95% confidence interval [CI]: 1.78-3.02), anemia (OR: 4.42; 95% CI: 3.35-5.83), coagulopathy (OR: 4.72; 95% CI: 2.94-7.57), diabetes (OR: 1.45; 95% CI: 1.14-1.84), liver disease (OR: 2.37; 95% CI: 1.27-4.43), pulmonary circulation disorders (OR: 3.28; 95% CI: 1.71-6.29), and metastatic cancer (OR: 5.85; 95% CI: 2.63-13.0; p < 0.01 for all). The ICER of preoperative T/S was $3,576 per ERT prevented. One-way sensitivity analysis demonstrated that the risk of transfusion should exceed 4.12% to justify preoperative T/S. Conclusion Routine preoperative T/S does not represent a cost-effective practice for these surgeries using nationally representative data. A selective T/S policy for high-risk patients may reduce costs | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a anterior skull base | |
650 | 4 | |a blood grouping and crossmatching | |
650 | 4 | |a blood loss | |
650 | 4 | |a blood transfusion | |
650 | 4 | |a skull base surgery | |
650 | 4 | |a surgical | |
700 | 1 | |a Allen, Meredith |e verfasserin |4 aut | |
700 | 1 | |a Karabon, Patrick |e verfasserin |4 aut | |
700 | 1 | |a Hojjat, Houmehr |e verfasserin |4 aut | |
700 | 1 | |a Shenouda, Kerolos |e verfasserin |4 aut | |
700 | 1 | |a Hussein, Inaya Hajj |e verfasserin |4 aut | |
700 | 1 | |a Jacob, Jeffrey T |e verfasserin |4 aut | |
700 | 1 | |a Svider, Peter F |e verfasserin |4 aut | |
700 | 1 | |a Folbe, Adam J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of neurological surgery. Part B, Skull base |d 2012 |g 83(2022), Suppl 2 vom: 14. Juni, Seite e449-e458 |w (DE-627)NLM224675842 |x 2193-6331 |7 nnns |
773 | 1 | 8 | |g volume:83 |g year:2022 |g number:Suppl 2 |g day:14 |g month:06 |g pages:e449-e458 |
856 | 4 | 0 | |u http://dx.doi.org/10.1055/s-0041-1730896 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 83 |j 2022 |e Suppl 2 |b 14 |c 06 |h e449-e458 |